Table 3.
Fcγ receptor 3B (FCGR3B) distribution in rheumatoid factor (RF) positive and negative patients
FCGR3B CN | RF negative, N (frequency) |
RF positive, N (frequency) |
OR (95% CI) | p Value | |
---|---|---|---|---|---|
New Zealand (RA) | <2 | 14 (0.156) | 41 (0.094) | 0.56 (0.29 to 1.08) | 0.08 |
2 | 76 (0.844) | 396 (0.896) | 1.00 | ||
UK RA | <2 | 10 (0.115) | 5 (0.034) | 0.27 (0.09 to 0.82) | 0.02 |
2 | 77 (0.885) | 142 (0.966) | 1.00 | ||
Dutch RA | <2 | 16 (0.112) | 64 (0.124) | 1.13 (0.63 to 2.02) | 0.69 |
2 | 127 (0.888) | 451 (0.876) | 1.00 | ||
Combined RA* | <2 | 40 (0.125) | 110 (0.100) | 0.78 (0.53 to 1.14) | 0.20 |
2 | 280 (0.875) | 989 (0.900) | 1.00 |
p=0.055, Breslow–Day.
CN, copy number; RA, rheumatoid arthritis.